AR057410A1 - Formulacion de liberacion prolongada de principios activos de medicamentos - Google Patents
Formulacion de liberacion prolongada de principios activos de medicamentosInfo
- Publication number
- AR057410A1 AR057410A1 ARP060102755A ARP060102755A AR057410A1 AR 057410 A1 AR057410 A1 AR 057410A1 AR P060102755 A ARP060102755 A AR P060102755A AR P060102755 A ARP060102755 A AR P060102755A AR 057410 A1 AR057410 A1 AR 057410A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation
- prolonged release
- medicines
- active principles
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una formulacion para una liberacion prolongada de un principio activo que presenta una solubilidad dependiente del pH. La formulacion comprende un excipiente matricial a base de polímero hidrofilo que contiene una dosis determinada del principio activo, y también comprende uno o varios agentes acidificantes en forma de una sal ácida de un ácido orgánico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0506539A FR2887455B1 (fr) | 2005-06-28 | 2005-06-28 | Formulation a liberation prolongee de principes actifs de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057410A1 true AR057410A1 (es) | 2007-12-05 |
Family
ID=35708770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102755A AR057410A1 (es) | 2005-06-28 | 2006-06-27 | Formulacion de liberacion prolongada de principios activos de medicamentos |
Country Status (31)
Country | Link |
---|---|
US (1) | US20080089936A1 (es) |
EP (1) | EP1904037A1 (es) |
JP (1) | JP2008546830A (es) |
KR (1) | KR101387839B1 (es) |
CN (1) | CN101217943B (es) |
AR (1) | AR057410A1 (es) |
AU (1) | AU2006264856B2 (es) |
BR (1) | BRPI0612990A2 (es) |
CA (1) | CA2611125A1 (es) |
CR (1) | CR9567A (es) |
DO (1) | DOP2006000144A (es) |
EA (1) | EA013745B1 (es) |
EC (1) | ECSP078010A (es) |
FR (1) | FR2887455B1 (es) |
GT (1) | GT200600275A (es) |
HK (1) | HK1122731A1 (es) |
HN (1) | HN2006023741A (es) |
IL (1) | IL187901A0 (es) |
MA (1) | MA29560B1 (es) |
MX (1) | MX2007016238A (es) |
MY (1) | MY150069A (es) |
NO (1) | NO20080420L (es) |
NZ (1) | NZ564069A (es) |
PA (1) | PA8682701A1 (es) |
PE (1) | PE20070098A1 (es) |
TN (1) | TNSN07438A1 (es) |
TW (1) | TWI446934B (es) |
UA (1) | UA91553C2 (es) |
UY (1) | UY29637A1 (es) |
WO (1) | WO2007003746A1 (es) |
ZA (1) | ZA200711035B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2090297A1 (en) * | 2008-02-13 | 2009-08-19 | Boehringer Ingelheim International GmbH | Formulations of flibanserin |
EA201490626A1 (ru) * | 2011-09-14 | 2014-08-29 | Поузен Инк. | Поэтапное дозирование клопидогрела |
IT201700011337A1 (it) * | 2017-02-02 | 2018-08-02 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Compressa multistrato per la somministrazione di magnesio |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655266B1 (fr) * | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
EP0621777B1 (de) * | 1992-01-17 | 1996-09-11 | ALFATEC-PHARMA GmbH | Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung |
EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
WO2000040205A2 (en) * | 1999-01-05 | 2000-07-13 | Copley Pharmaceutical Inc. | Sustained release formulation with reduced moisture sensitivity |
EP1064937A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
JP4933033B2 (ja) * | 2003-03-17 | 2012-05-16 | 武田薬品工業株式会社 | 放出制御組成物 |
AU2004287485A1 (en) * | 2003-11-05 | 2005-05-19 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
-
2005
- 2005-06-28 FR FR0506539A patent/FR2887455B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-23 PA PA20068682701A patent/PA8682701A1/es unknown
- 2006-06-26 MY MYPI20063017A patent/MY150069A/en unknown
- 2006-06-26 JP JP2008518906A patent/JP2008546830A/ja active Pending
- 2006-06-26 EP EP06778663A patent/EP1904037A1/fr not_active Withdrawn
- 2006-06-26 AU AU2006264856A patent/AU2006264856B2/en not_active Ceased
- 2006-06-26 MX MX2007016238A patent/MX2007016238A/es active IP Right Grant
- 2006-06-26 CA CA002611125A patent/CA2611125A1/fr not_active Abandoned
- 2006-06-26 KR KR1020077030484A patent/KR101387839B1/ko active IP Right Grant
- 2006-06-26 WO PCT/FR2006/001466 patent/WO2007003746A1/fr active Application Filing
- 2006-06-26 DO DO2006000144A patent/DOP2006000144A/es unknown
- 2006-06-26 BR BRPI0612990-0A patent/BRPI0612990A2/pt not_active Application Discontinuation
- 2006-06-26 CN CN2006800231372A patent/CN101217943B/zh active Active
- 2006-06-26 ZA ZA200711035A patent/ZA200711035B/xx unknown
- 2006-06-26 UA UAA200800914A patent/UA91553C2/ru unknown
- 2006-06-26 NZ NZ564069A patent/NZ564069A/en not_active IP Right Cessation
- 2006-06-26 EA EA200800150A patent/EA013745B1/ru not_active IP Right Cessation
- 2006-06-27 HN HN2006023741A patent/HN2006023741A/es unknown
- 2006-06-27 AR ARP060102755A patent/AR057410A1/es unknown
- 2006-06-27 GT GT200600275A patent/GT200600275A/es unknown
- 2006-06-28 TW TW095123267A patent/TWI446934B/zh not_active IP Right Cessation
- 2006-06-28 PE PE2006000753A patent/PE20070098A1/es active IP Right Grant
- 2006-06-29 UY UY29637A patent/UY29637A1/es unknown
-
2007
- 2007-11-26 TN TNP2007000438A patent/TNSN07438A1/en unknown
- 2007-12-03 US US11/949,291 patent/US20080089936A1/en not_active Abandoned
- 2007-12-04 IL IL187901A patent/IL187901A0/en unknown
- 2007-12-06 CR CR9567A patent/CR9567A/es unknown
- 2007-12-13 EC EC2007008010A patent/ECSP078010A/es unknown
- 2007-12-24 MA MA30501A patent/MA29560B1/fr unknown
-
2008
- 2008-01-22 NO NO20080420A patent/NO20080420L/no not_active Application Discontinuation
- 2008-12-29 HK HK08114006.5A patent/HK1122731A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2557303T3 (es) | Agente terapéutico para la estenosis del canal espinal | |
CL2009002073A1 (es) | Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares. | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
CY1120377T1 (el) | Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη | |
ES2545959T3 (es) | Un medicamento consistente en un derivado de carboestirilo y donepezilo para el tratamiento de la enfermedad de Alzheimer | |
AR067309A1 (es) | Formulaciones farmaceuticas que contienen derivados de acido lipoico | |
ATE476176T1 (de) | Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung | |
ES2509117T3 (es) | Composición farmacéutica oral que contiene dabigatran etexilato | |
AR072842A1 (es) | Composicion farmaceutica estabilizada que comprende un ingrediente farmaceuticamente activo no peptidico | |
MX2010004222A (es) | Formulaciones solidas de compuestos cristalinos. | |
CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
AR034517A1 (es) | Formulacion farmaceutica | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
ATE549016T1 (de) | Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe | |
AR054729A1 (es) | Sistema de administracion | |
AR057410A1 (es) | Formulacion de liberacion prolongada de principios activos de medicamentos | |
ECSP099251A (es) | Formulaciones farmacéuticas | |
ES2531241T3 (es) | Composición farmacéutica líquida estable a base de trazodona | |
AR053144A1 (es) | Composicion farmaceutica solida que comprende telitromicina | |
DOP2006000184A (es) | Forma farmacéutica con liberación sostenida independiente del ph de un ingrediente activo, para ingredientes activos que tienen una solubilidad que depende en gran medida del ph | |
DOP2006000128A (es) | Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales | |
CR9563A (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales | |
AR070617A1 (es) | Formulacion farmaceutica que comprende oxabispidinas/236 | |
TW200833325A (en) | Pharmaceutical composition comprising ascorbic acid | |
UY31743A1 (es) | Metoclopramida de liberacion prolongada 12 horas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |